HomeHealth EconomicsNew publications in health economics and genomics January 7, 2026

New publications in health economics and genomics January 7, 2026

Health Economics

January 7, 2026

byhealthnova

Spread the love

happy new year! 5 publications since last update:

Utilization, reimbursement and barriers to access to cancer treatment sequencing testing in Asia Pacific: a KSMO initiative to address cancer treatment inequities | link
Comparative cost analysis of diagnostic multi-omics platforms for decision support in advanced cancer – Tumor Profiler Melanoma Project Results | link
Sequencing every UK newborn: why cold storage economics should shape policy | link
The value of functional genomics: a conditional valuation | link
Cost-effectiveness analysis model of a feasible genomic alteration testing strategy incorporating multiple modalities and sizes of next-generation sequencing panels for non-small cell lung cancer | link

I’m excited to share some other publications I missed this week. Please let me know. I post these updates every Tuesday, but only if I see a related publication. If you don’t see any updates on Tuesday, assume it was a quiet week for publications in the fields of health economics and genomics.

Keep Up to Date with the Most Important News

Keep Up to Date with the Most Important News

New publications in health economics and genomics January 7, 2026

Keep Up to Date with the Most Important News

Leave a Reply Cancel reply

6 Tips for Overcoming Health System Obstacles to Get Drugs to Prevent HIV

Brain Health Challenge: Exercises to Strengthen Your Brain

Recommended for You

Health status preferences revisited after 20 years: setting new EQ-5D-3L values ​​for the Netherlands

New Alzheimer’s disease breakthrough calls for a new definition of dementia friendliness

With Medicaid out of the picture, hospitals can go one step further with 340B.

Menstrual cramps and heavy bleeding cost the Australian economy billions of dollars in lost productivity each year: Study

Using the Economic Value of Social Contact to Assess the Costs and Benefits of Non-Pharmaceutical Pandemic Measures | European Journal of Health Economics

New publications in health economics and genomics January 20, 2026

A new approach for cheap medicines and mental health care. Will the budget make us healthier?

Australia can make a large quantity of all GP visits. So why are we not?

Mental health services are overloaded. We must pay them to improve your treatment

Digsators can be cheaper or free of charge. But we have different access depending on the postal code

Do you get the latest information on cobid, flu and other shots? Depending on who the GP is

We have too few elderly caregivers to take care of the elderly. why? And what can we do about it?

The government has a new plan for the elderly nursing. There is something that changes

Prevention treatment is free by law, but many Americans are wrong -especially if they are poor, those who are colored or university degrees

Why is Medicare not included dentists? It’s time to change this -here is a way

Is private hospital really a problem? And are more public funds answering?

Geting the antivirus for covid too often depends on where you live and how rich you are.

The primary care includes more than GP. The new review shows how the patient can take a better approach.

Personal health insurance companies are currently offering GP remote health services. Is this a danger of Medicare?

Doctors’ bills often come with sticker shocks for patients -but health insurance can be re -creation.

What is the pharmacy benefit manager? Health economists explain how competition is raising the price of medicines to everyone.

Too many Australians miss the essential medical services every year. The method of fixing the GP Desert is as follows.

The hospital will earn $ 1.7 billion federal funds. Can this reduce the waiting time?

Labor and Union promised to file a mass claim for GP. Medicare Boost means that the patient means

If the vaccination rate decreases, children have a risk of preventive diseases. The government needs a new strategy to increase absorption.

The main parties want nine in the 10GP visit by 2030. Here’s why you shouldn’t be aimed at 100%:

The UK subsidizes the same drugs such as Ozempic for weight loss. Can Australia follow?

50 new emergency treatment clinics are on the card. But are existing people working? What we know so far is:

Australia’s PBS means that consumers pay less for expensive medicines. The method of working with this system is as follows.

The budget offers cheaper medicines and more bulk claims, but leaves long -term health reform.

Increasing the rate of increase in disposable income and alcohol mortality rate of Polish furniture

The 60 -day script had to save time and money. Then why are we still waiting for cheaper medicines?

Health status preferences revisited after 20 years: setting new EQ-5D-3L values for the Netherlands